GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
IT1016489B
(it)
|
1974-03-18 |
1977-05-30 |
Isf Spa |
Inalatore
|
ZA81219B
(en)
|
1980-01-23 |
1982-01-27 |
Schering Corp |
Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
|
JPS6235216A
(ja)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
不均質物質層の層厚非破壊測定方法および装置
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
GB9816837D0
(en)
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
WO1993018007A1
(en)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Novel carbostyril derivative
|
JP3192424B2
(ja)
|
1992-04-02 |
2001-07-30 |
スミスクライン・ビーチャム・コーポレイション |
アレルギーまたは炎症疾患の治療用化合物
|
SK279958B6
(sk)
|
1992-04-02 |
1999-06-11 |
Smithkline Beecham Corporation |
Zlúčeniny s protialergickým a protizápalovým účink
|
WO1993019751A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
US6596260B1
(en)
|
1993-08-27 |
2003-07-22 |
Novartis Corporation |
Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
|
ES2216418T3
(es)
|
1995-12-07 |
2004-10-16 |
Jago Research Ag |
Boquilla para un inhalador para la administracion de varias dosis de un polvo seco farmacologico.
|
EP0883415B1
(en)
|
1996-02-21 |
2002-05-02 |
Schering Corporation |
Powdered medication inhaler
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
WO1999016766A1
(fr)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de benzodioxole
|
NZ503809A
(en)
|
1997-12-19 |
2002-04-26 |
Schering Ag |
Ortho-anthranilamide derivatives as anti-coagulants
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
WO2000000531A1
(en)
|
1998-06-30 |
2000-01-06 |
The Dow Chemical Company |
Polymer polyols and a process for the production thereof
|
DE19834044A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Neue substituierte Pyrazolderivate
|
DE19834047A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Substituierte Pyrazolderivate
|
IL141183A0
(en)
|
1998-08-04 |
2002-02-10 |
Astrazeneca Ab |
Amide derivatives useful as inhibitors of the production of cytokines
|
BR0009041A
(pt)
|
1999-03-17 |
2001-12-26 |
Astrazeneca Ab |
Derivado de amida, processo para a preparação deum derivado de amida, composição farmacêutica,uso de um derivado de amida, e, método paratratar doenças ou quadros clìnicos mediados porcitocinas
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
ES2244437T3
(es)
|
1999-05-04 |
2005-12-16 |
Schering Corporation |
Derivados de piperazina utiles como antagonistas de ccr5.
|
AU780983B2
(en)
|
1999-05-04 |
2005-04-28 |
Schering Corporation |
Piperidine derivatives useful as CCR5 antagonists
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
AU777012B2
(en)
|
1999-08-21 |
2004-09-30 |
Takeda Gmbh |
Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
|
DE19943635A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
DE19943634A1
(de)
|
1999-09-13 |
2001-04-12 |
Bayer Ag |
Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
DE19943639A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
|
DE19943636A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
AU780787B2
(en)
|
1999-09-17 |
2005-04-14 |
Millennium Pharmaceuticals, Inc. |
Benzamides and related inhibitors of factor Xa
|
GB9924092D0
(en)
|
1999-10-13 |
1999-12-15 |
Zeneca Ltd |
Pyrimidine derivatives
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
WO2003000840A2
(en)
|
2001-06-21 |
2003-01-03 |
Diversa Corporation |
Nitrilases
|
EA200201056A1
(ru)
|
2000-04-27 |
2003-04-24 |
Бёрингер Ингельхайм Фарма Кг |
Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств
|
DK1300407T4
(da)
|
2000-06-27 |
2011-09-05 |
S A L V A T Lab Sa |
Carbamater afledt af arylalkylaminer
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
AU7576001A
(en)
|
2000-08-05 |
2002-02-18 |
Glaxo Group Ltd |
6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
AR031176A1
(es)
|
2000-11-22 |
2003-09-10 |
Bayer Ag |
Nuevos derivados de pirazolpiridina sustituidos con piridina
|
WO2002051841A1
(en)
|
2000-12-22 |
2002-07-04 |
Almirall Prodesfarma Ag |
Quinuclidine carbamate derivatives and their use as m3 antagonists
|
RU2282629C2
(ru)
|
2000-12-28 |
2006-08-27 |
Альмиралль Продесфарма Аг |
Производные хинуклидина, способ их получения и фармацевтическая композиция на их основе
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
SE0100567D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
ATE365720T1
(de)
|
2001-03-08 |
2007-07-15 |
Glaxo Group Ltd |
Agonisten von beta-adrenorezeptoren
|
JP4143413B2
(ja)
|
2001-03-22 |
2008-09-03 |
グラクソ グループ リミテッド |
β2−アドレナリン受容体アゴニストとしてのホルムアニリド誘導体
|
EP1383786B1
(en)
|
2001-04-30 |
2008-10-15 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
DE60227254D1
(de)
|
2001-06-12 |
2008-08-07 |
Glaxo Group Ltd |
Neue anti inflammatorische 17.alpha.-heterozyklische ester von 17.beta.-carbothioat androstan derivativen
|
ES2316599T3
(es)
|
2001-09-14 |
2009-04-16 |
Glaxo Group Limited |
Derivados de fenetanolamina para el tratamiento de enfermedades respiratorias.
|
CZ2004501A3
(cs)
|
2001-10-17 |
2004-09-15 |
Ucb, S.A. |
Chinuklidinové deriváty, způsoby jejich přípravy a jejich použití jako M2 a/nebo M3 inhibitoru muskarinového receptoru
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
MY130622A
(en)
|
2001-11-05 |
2007-07-31 |
Novartis Ag |
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
WO2003048181A1
(en)
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
WO2003053966A2
(en)
|
2001-12-20 |
2003-07-03 |
Laboratorios S.A.L.V.A.T., S.A. |
1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
WO2003062259A2
(en)
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
WO2004078163A2
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
WO2003078435A1
(en)
|
2002-03-13 |
2003-09-25 |
Pharmacia & Upjohn Company Llc |
Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
|
AU2003230700A1
(en)
|
2002-03-26 |
2003-10-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
EP1490062B1
(en)
|
2002-03-26 |
2007-12-19 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US7282591B2
(en)
|
2002-04-11 |
2007-10-16 |
Merck & Co., Inc. |
1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
EP1497261B1
(en)
|
2002-04-25 |
2007-12-19 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
US6747043B2
(en)
|
2002-05-28 |
2004-06-08 |
Theravance, Inc. |
Alkoxy aryl β2 adrenergic receptor agonists
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
AU2003243870B2
(en)
|
2002-06-25 |
2008-11-20 |
Merck Frosst Canada Ltd |
8-(biaryl) quinoline PDE4 inhibitors
|
AU2003281219A1
(en)
|
2002-07-02 |
2004-01-23 |
Bernard Cote |
Di-aryl-substituted-ethane pyridone pde4 inhibitors
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
AU2003281355A1
(en)
|
2002-07-08 |
2004-01-23 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
PE20050130A1
(es)
|
2002-08-09 |
2005-03-29 |
Novartis Ag |
Compuestos organicos
|
EP1542987A1
(en)
|
2002-08-10 |
2005-06-22 |
ALTANA Pharma AG |
Piperidine-n-oxide-derivatives
|
AU2003260376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-pyridazones and phthalazones as pde4 inhibitors
|
AU2003255376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
CA2494650A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Pyridazinone-derivatives as pde4 inhibitors
|
AU2003263216A1
(en)
|
2002-08-17 |
2004-03-11 |
Nycomed Gmbh |
Benzonaphthyridines with PDE 3/4 inhibiting activity
|
CA2495597A1
(en)
|
2002-08-17 |
2004-03-04 |
Altana Pharma Ag |
Novel phenanthridines
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
EP1532113B1
(en)
|
2002-08-21 |
2008-08-06 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US7288562B2
(en)
|
2002-08-23 |
2007-10-30 |
Ranbaxy Laboratories Limited |
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
|
JP4619786B2
(ja)
|
2002-08-29 |
2011-01-26 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための3−(スルホンアミドエチル)−インドール誘導体
|
EP1539164B1
(en)
|
2002-08-29 |
2006-12-20 |
ALTANA Pharma AG |
2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
DE60311662T2
(de)
|
2002-08-29 |
2007-10-25 |
Altana Pharma Ag |
3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
CA2497903A1
(en)
|
2002-09-18 |
2004-04-01 |
Ono Pharmaceutical Co., Ltd. |
Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
|
MY136840A
(en)
|
2002-09-19 |
2008-11-28 |
Schering Corp |
Pyrazolopyridines as cyclin dependent kinase inhibitors
|
US6992080B2
(en)
|
2002-09-19 |
2006-01-31 |
Schering Corporation |
Imidazopyridines as cyclin dependent kinase inhibitors
|
WO2004026248A2
(en)
|
2002-09-20 |
2004-04-01 |
Merck & Co., Inc. |
Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
CA2499314C
(en)
|
2002-10-11 |
2010-08-24 |
Pfizer Inc. |
Indole derivatives as beta-2 agonists
|
EP1440966A1
(en)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Indole derivatives useful for the treatment of diseases
|
AU2003298094A1
(en)
|
2002-10-22 |
2004-05-13 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
CA2503015A1
(en)
|
2002-10-23 |
2004-05-06 |
Glenmark Pharmaceuticals Ltd. |
Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
DE60320007T2
(de)
|
2002-10-28 |
2009-06-18 |
Glaxo Group Ltd., Greenford |
Phenthanolamin-Derivate zur Behandlung von Atemwegserkrankungen
|
GB0225287D0
(en)
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10261874A1
(de)
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
TWI299664B
(en)
|
2003-01-06 |
2008-08-11 |
Osi Pharm Inc |
(2-carboxamido)(3-amino)thiophene compounds
|
CA2512987C
(en)
|
2003-01-21 |
2011-06-14 |
Merck & Co., Inc. |
17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
MXPA05010444A
(es)
|
2003-04-03 |
2005-11-04 |
Merck Patent Gmbh |
Compuestos de carbonilo.
|
EP1479680A1
(en)
|
2003-05-19 |
2004-11-24 |
Aventis Pharma Deutschland GmbH |
Azaindole derivatives as Factor Xa inhibitors
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
AU2004245174A1
(en)
|
2003-06-10 |
2004-12-16 |
Ace Biosciences A/S |
Extracellular Aspergillus polypeptides
|
US7144907B2
(en)
|
2003-09-03 |
2006-12-05 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
GB2407042B
(en)
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US20050165031A1
(en)
|
2003-11-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Urea derivatives as ABL modulators
|
KR100807920B1
(ko)
|
2003-12-23 |
2008-02-27 |
화이자 인코포레이티드 |
신규한 퀴놀린 유도체
|
JP2007526324A
(ja)
|
2004-03-02 |
2007-09-13 |
スミスクライン・ビーチャム・コーポレイション |
Akt活性のある阻害剤
|
GB0410712D0
(en)
|
2004-05-13 |
2004-06-16 |
Novartis Ag |
Organic compounds
|
DE102004045796A1
(de)
|
2004-09-22 |
2006-03-23 |
Merck Patent Gmbh |
Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
|
AR053992A1
(es)
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
AU2005317870A1
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Pyridine carboxamide derivatives for use as anticancer agents
|
EP1841431A4
(en)
|
2005-01-26 |
2009-12-09 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
|
KR101300831B1
(ko)
|
2005-03-21 |
2013-08-30 |
에스*바이오 피티이 리미티드 |
이미다조[1,2-a]피리딘 유도체, 이의 제조 방법 및 그의약학적 용도
|
GB0507575D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
WO2007017143A1
(en)
*
|
2005-07-29 |
2007-02-15 |
F. Hoffmann-La Roche Ag |
Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
ATE478852T1
(de)
|
2005-09-09 |
2010-09-15 |
Schering Corp |
Neue 4-cyano-, 4-amino-, und 4- aminomethylderivative von pyrazoloä1,5- aüpyridinen, pyrazoloä1,5-cüpyrimidinen und 2h- indazolverbindungen und 5-cyano-, 5-amino- und 5- aminomethylderivative von imidazoä1,2-aüpyridinen,und imidazoä1,5-aüpyrazinverbindungen als inhibitoren der cyclinabhänggen kinase
|
KR20080074161A
(ko)
|
2005-12-08 |
2008-08-12 |
노파르티스 아게 |
EPHB 및 VEGFR2 키나아제 억제제로서의피라졸로[1,5-a]피리딘-3-카르복실산
|
KR20070077468A
(ko)
*
|
2006-01-23 |
2007-07-26 |
크리스탈지노믹스(주) |
단백질 키나아제 활성을 저해하는 이미다조피리딘 유도체,이의 제조방법 및 이를 함유하는 약학 조성물
|
GB0604937D0
(en)
|
2006-03-10 |
2006-04-19 |
Novartis Ag |
Organic compounds
|
BRPI0710110A2
(pt)
|
2006-03-31 |
2011-08-02 |
Novartis Ag |
compostos orgánicos
|
US20080015193A1
(en)
|
2006-06-20 |
2008-01-17 |
Mendoza Jose S |
Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
CN101511828A
(zh)
*
|
2006-09-06 |
2009-08-19 |
霍夫曼-拉罗奇有限公司 |
作为蛋白激酶抑制剂的杂芳基衍生物
|
MX2009004716A
(es)
|
2006-11-03 |
2009-07-17 |
Irm Llc |
Compuestos y composiciones en la forma de inhibidores de quinasa de proteina.
|
ME02372B
(me)
|
2006-11-22 |
2016-06-20 |
Incyte Holdings Corp |
Imidazotriazini i imidazopiramidini kao inhibitori kinaze
|
AU2007337895C1
(en)
|
2006-12-22 |
2014-07-31 |
Astex Therapeutics Limited |
Tricyclic amine derivatives as protein tyrosine kinase inhibitors
|
ES2449482T3
(es)
|
2007-01-09 |
2014-03-19 |
Amgen Inc. |
Derivados de bis-aril-amida útiles para el tratamiento de cáncer
|
WO2008134553A1
(en)
|
2007-04-26 |
2008-11-06 |
Xenon Pharmaceuticals Inc. |
Methods of using bicyclic compounds in treating sodium channel-mediated diseases
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
EP2162445B1
(en)
|
2007-06-05 |
2013-11-27 |
Takeda Pharmaceutical Company Limited |
Heterobicyclic compounds as kinase inhibitors
|
TWI519508B
(zh)
|
2007-06-12 |
2016-02-01 |
Achaogen Inc |
抗菌劑
|
JP2010533729A
(ja)
|
2007-07-17 |
2010-10-28 |
プレキシコン,インコーポレーテッド |
キナーゼ調節のための化合物と方法、及びそのための適応
|
US8217064B2
(en)
|
2007-12-20 |
2012-07-10 |
Envivo Pharmaceuticals, Inc. |
Tetrasubstituted benzenes
|
WO2009103778A1
(en)
|
2008-02-19 |
2009-08-27 |
Novasaid Ab |
Compounds and methods
|
ES2548135T3
(es)
|
2008-05-13 |
2015-10-14 |
Novartis Ag |
Heterociclos condensados que contienen nitrógeno y composiciones de los mismos como inhibidores de quinasa
|
AU2009279936A1
(en)
|
2008-08-05 |
2010-02-11 |
Banyu Pharmaceutical Co., Ltd. |
Therapeutic compounds
|
EP2210891A1
(en)
|
2009-01-26 |
2010-07-28 |
Domain Therapeutics |
New adenosine receptor ligands and uses thereof
|
WO2010088000A2
(en)
|
2009-02-02 |
2010-08-05 |
Angion Biomedica Corp. |
Antifibrotic compounds and uses thereof
|
MY162604A
(en)
|
2009-08-17 |
2017-06-30 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
AU2010343102B2
(en)
|
2009-12-29 |
2016-03-24 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
JP2013530963A
(ja)
|
2010-06-09 |
2013-08-01 |
レセプトス インコーポレイテッド |
新規のglp−1受容体安定化薬および調節薬
|
SG186989A1
(en)
|
2010-07-14 |
2013-02-28 |
Novartis Ag |
Ip receptor agonist heterocyclic compounds
|
JP2013538798A
(ja)
*
|
2010-08-03 |
2013-10-17 |
グラフィニティ ファーマシューティカルズ ゲーエムベーハー |
アフィニティクロマトグラフィーによる抗体およびFc融合タンパク質精製のためのリガンド
|
EP2617721A4
(en)
|
2010-08-25 |
2014-01-08 |
Neopharm Co Ltd |
NEW HETEROCYCLIC COMPOUND AND COMPOSITION FOR THE TREATMENT OF INFLAMMATORY DISORDERS THEREWITH
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
US9199981B2
(en)
|
2011-09-01 |
2015-12-01 |
Novartis Ag |
Compounds and compositions as C-kit kinase inhibitors
|